Evidence map›Paper›PMID 31558929›Full record

ArticleThe Pan African medical journal2019

Histo-epidemiological aspects of gynecological and breast cancers at the University Teaching Hospital of Yaoundé.

Armand Duclaire Djimeli Kemo, Blaise Nkegoum, Charlette Nangue, Félicité Djuikwo, Landry Beyala Bita'a, Pierre Marie Tebeu

Abstract read
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Breast Cancer in Togolese Women: Imaging and Clinicopathological Findings.Breast cancer : basic and clinical research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Armand Duclaire Djimeli KemoHigher Institute of Health Sciences, Université des Montagnes, Bangangté, Cameroon.
Blaise NkegoumDepartment of Pathological Anatomy, University Teaching Hospital of Yaoundé, Yaoundé, Cameroon.
Charlette NangueDepartment of Pathological Anatomy, University Teaching Hospital of Yaoundé, Yaoundé, Cameroon.
Félicité DjuikwoDepartment of Parasitology, Université des Montagnes, Bangangté, Cameroon.
Landry Beyala Bita'aMeilleur Accès aux soins de Santé (M.A. SANTE), Yaoundé, Cameroon.
Pierre Marie TebeuGynecology-Obstetrics Service, University Teaching Hospital of Yaoundé, Yaoundé, Cameroon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCancer is a public health problem that affect women more than men. The aim of the study was to describe the epidemiological and histopathological features of gynecological malignancies in the city of Yaoundé, Cameroon.

methodsThis was a descriptive cross-sectional study of histologically proven gynecological cancers over a 10-year period (2008-2017) in the Gynecology and Pathological Anatomy Departments of the University Teaching Hospital of Yaoundé.

resultsA total of 682 cancers were identified among which, 342 gynecological cancers, for an overall frequency of 50.1% and an annual frequency of 34.2 cases on average. There was a trend suggesting an increase annual frequency over time. The cervix was the most frequent location with 182 cases (53.2%); followed by breast with 96 cases (28.1%); endometrium with 33 cases (9.7%) and ovaries 15 cases (4.4%). These patients were on average 51.9±13.7 years old, mostly housewives (56.8%), married (60.4%), multiparous (61.3%) and referred (62.6%). Histopathologically, cervical cancer was predominantly squamous cell carcinoma (86.8%), invasive (80.9%) and well differentiated (45.5%). For breast cancers, the majority were ductal carcinomas (78.1%), invasive (92%), and histological grade SBR II (50.6%). The most common histopathological types of endometrial and ovarian cancer were adenocarcinoma (72.2%) and serous cystadenocarcinoma (46.7%), respectively.

conclusionGynecological cancers are common. Screening is expected to increase at 30 years for cervical cancer and start at age 40 with mammography for breast cancer.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsCameroonCarcinoma, Ductal, BreastCross-Sectional StudiesEndometrial NeoplasmsFemaleGenital Neoplasms, FemaleHospitals, UniversityHumansMass ScreeningMiddle AgedOvarian NeoplasmsUterine Cervical NeoplasmsCameroonepidemiologyGynecological cancershistopathologyYaoundé

Identifiers

PMID31558929
PMCPMC6754847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.